Literature DB >> 29121613

Mussel-inspired polydopamine-polyethylenimine conjugated nanoparticles as efficient gene delivery vectors for mammalian cells.

Ayushi Priyam1, Prachi Nagar1, Ashwani Kumar Sharma1, Pradeep Kumar2.   

Abstract

Efficient delivery of DNA to cells is the primary concern to address the objective of gene therapy. Many attempts have been made to develop polymeric carriers for gene delivery. To have an efficient carrier, it is vital to understand the properties of the vector for better stability, transfection efficiency and minimal toxicity. Branched polyethylenimine (bPEI) has been considered as the 'gold standard' for gene delivery but suffers a major drawback of exhibiting high cytotoxicity. Here, we have attempted to develop a mussel-derived polymer, polydopamine (PDA), conjugated polyethylenimine nanoparticles in such a way that the toxic nature of bPEI is suppressed by the conversion of free primary amine groups to secondary and tertiary amines. Keeping the amount of PDA fixed, varying amounts of bPEIs of different molecular weights (25, 10 and 1.8kDa) were conjugated via Michael addition and/or Schiff base. A trend in hydrodynamic size of the conjugated nanoparticles was observed in the range from 160 to 300nm and zeta potential from +12-30mV in the projected three series, viz., (i) PDA1-25bPEI0.5, PDA1-25bPEI1, PDA1-25bPEI2; (ii) PDA1-10bPEI0.5, PDA1-10bPEI1, PDA1-10bPEI2; and (iii) PDA1-1.8bPEI0.5, PDA1-1.8bPEI1, PDA1-1.8bPEI2. A visible trend in the DNA condensation ability and buffering capacity was also noticed. Further, cell cytotoxicity assays revealed that pDNA complexes of PDA-bPEI nanoparticles were non-toxic to mammalian cells and these complexes exhibited several folds higher transfection efficiency than the complexes of native bPEIs as demonstrated by fluorescence measurements and flow cytometry. Altogether, the results advocate the promising potential of these conjugated nanoparticles for future in vivo applications.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; Nanocarriers; Plasmid DNA; Polydopamine; Polyethylenimine; Transfection

Mesh:

Substances:

Year:  2017        PMID: 29121613     DOI: 10.1016/j.colsurfb.2017.10.063

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  5 in total

1.  Durable Surfaces from Film-Forming Silver Assemblies for Long-Term Zero Bacterial Adhesion without Toxicity.

Authors:  Hossein Yazdani-Ahmadabadi; Demian F Felix; Kai Yu; Han H Yeh; Haiming D Luo; Sara Khoddami; Lily E Takeuchi; Amal Alzahrani; Srinivas Abbina; Yan Mei; Ladan Fazli; Dana Grecov; Dirk Lange; Jayachandran N Kizhakkedathu
Journal:  ACS Cent Sci       Date:  2022-04-27       Impact factor: 18.728

Review 2.  Recent Advances in a Polydopamine-Mediated Antimicrobial Adhesion System.

Authors:  Indu Singh; Gagan Dhawan; Seema Gupta; Pradeep Kumar
Journal:  Front Microbiol       Date:  2021-01-12       Impact factor: 5.640

3.  Sialic acid-engineered mesoporous polydopamine dual loaded with ferritin gene and SPIO for achieving endogenous and exogenous synergistic T2-weighted magnetic resonance imaging of HCC.

Authors:  Kai Fan; Chengying Lu; Gaofeng Shu; Xiu-Ling Lv; Enqi Qiao; Nannan Zhang; Minjiang Chen; Jingjing Song; Fazong Wu; Zhongwei Zhao; Xiaoling Xu; Min Xu; Chunmiao Chen; Weibin Yang; Jihong Sun; Yongzhong Du; Jiansong Ji
Journal:  J Nanobiotechnology       Date:  2021-03-17       Impact factor: 10.435

4.  Dimethylamino group modified polydopamine nanoparticles with positive charges to scavenge cell-free DNA for rheumatoid arthritis therapy.

Authors:  Ying Chen; Yonglin Wang; Xianfang Jiang; Jinhong Cai; Yuting Chen; Hanji Huang; Yuan Yang; Li Zheng; Jinmin Zhao; Ming Gao
Journal:  Bioact Mater       Date:  2022-03-28

Review 5.  Recent advances in melanin-like nanomaterials in biomedical applications: a mini review.

Authors:  Jihyo Park; Haeram Moon; Seonki Hong
Journal:  Biomater Res       Date:  2019-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.